Share-based Payment Arrangement, Expense of NEKTAR THERAPEUTICS from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NEKTAR THERAPEUTICS quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • NEKTAR THERAPEUTICS Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,072,000, a 43% decline year-over-year.
  • NEKTAR THERAPEUTICS Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $15,259,000, a 37% decline year-over-year.
  • NEKTAR THERAPEUTICS annual Share-based Payment Arrangement, Expense for 2024 was $21,612,000, a 35% decline from 2023.
  • NEKTAR THERAPEUTICS annual Share-based Payment Arrangement, Expense for 2023 was $33,388,000, a 42% decline from 2022.
  • NEKTAR THERAPEUTICS annual Share-based Payment Arrangement, Expense for 2022 was $57,320,000, a 39% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NEKTAR THERAPEUTICS Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,259,000 $3,072,000 -$2,319,000 -43% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $17,578,000 $3,486,000 -$1,932,000 -36% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $19,510,000 $3,898,000 -$2,102,000 -35% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $21,612,000 $4,803,000 -$2,451,000 -34% 01 Oct 2024 31 Dec 2024 10-K 14 Mar 2025 2024 FY
Q3 2024 $24,063,000 $5,391,000 -$2,758,000 -34% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $26,821,000 $5,418,000 -$2,548,000 -32% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $29,369,000 $6,000,000 -$4,019,000 -40% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $33,388,000 $7,254,000 -$5,484,000 -43% 01 Oct 2023 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $38,872,000 $8,149,000 -$4,369,000 -35% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $43,241,000 $7,966,000 -$3,137,000 -28% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $46,378,000 $10,019,000 -$10,942,000 -52% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $57,320,000 $12,738,000 -$9,667,000 -43% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $66,987,000 $12,518,000 -$12,139,000 -49% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $79,126,000 $11,103,000 -$12,611,000 -53% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $91,737,000 $20,961,000 -$2,937,000 -12% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $94,674,000 $22,405,000 +$418,000 +1.9% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q3 2021 $94,256,000 $24,657,000 +$990,000 +4.2% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $93,266,000 $23,714,000 +$343,000 +1.5% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $92,923,000 $23,898,000 -$1,338,000 -5.3% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $94,261,000 $21,987,000 -$3,021,000 -12% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $97,282,000 $23,667,000 -$1,213,000 -4.9% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $98,495,000 $23,371,000 -$1,151,000 -4.7% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $99,646,000 $25,236,000 -$149,000 -0.59% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $99,795,000 $25,008,000 +$802,000 +3.3% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $98,993,000 $24,880,000 +$1,593,000 +6.8% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $97,400,000 $24,522,000 +$3,863,000 +19% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $93,537,000 $25,385,000 +$5,436,000 +27% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $88,101,000 $24,206,000 +$12,709,000 +111% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $75,392,000 $23,287,000 +$14,452,000 +164% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $60,940,000 $20,659,000 +$12,560,000 +155% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $48,380,000 $19,949,000 +$11,765,000 +144% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $36,615,000 $11,497,000 +$4,440,000 +63% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 $32,175,000 $8,835,000 +$2,669,000 +43% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $29,506,000 $8,099,000 +$1,835,000 +29% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $27,671,000 $8,184,000 +$1,821,000 +29% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $25,850,000 $7,057,000 +$1,887,000 +36% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $23,963,000 $6,166,000 +$1,404,000 +29% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $22,559,000 $6,264,000 +$1,704,000 +37% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $20,855,000 $6,363,000 +$1,186,000 +23% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $19,669,000 $5,170,000 +$800,000 +18% 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
Q3 2015 $18,869,000 $4,762,000 +$640,000 +16% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $18,229,000 $4,560,000 +$396,000 +9.5% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $17,833,000 $5,177,000 +$816,000 +19% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q4 2014 $17,017,000 $4,370,000 -$173,000 -3.8% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $17,190,000 $4,122,000 -$442,000 -9.7% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $17,632,000 $4,164,000 -$192,000 -4.4% 01 Apr 2014 30 Jun 2014 10-Q 01 Aug 2014 2014 Q2
Q1 2014 $17,824,000 $4,361,000 +$116,000 +2.7% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015 2015 Q1
Q4 2013 $17,708,000 $4,543,000 +$359,000 +8.6% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $17,349,000 $4,564,000 +$584,000 +15% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $16,765,000 $4,356,000 +$555,000 +15% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $16,210,000 $4,245,000 +$11,000 +0.26% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $16,199,000 $4,184,000 -$200,000 -4.6% 01 Oct 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
Q3 2012 $16,399,000 $3,980,000 -$839,000 -17% 01 Jul 2012 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $17,238,000 $3,801,000 -$1,079,000 -22% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2
Q1 2012 $18,317,000 $4,234,000 -$568,000 -12% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q4 2011 $18,885,000 $4,384,000 01 Oct 2011 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $4,819,000 +$208,000 +4.5% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $4,880,000 +$519,000 +12% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q1 2011 $4,802,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
Q3 2010 $4,611,000 01 Jul 2010 30 Sep 2010 10-Q 04 Nov 2011 2011 Q3
Q2 2010 $4,361,000 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011 2011 Q2

NEKTAR THERAPEUTICS Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $21,612,000 -$11,776,000 -35% 01 Jan 2024 31 Dec 2024 10-K 14 Mar 2025 2024 FY
2023 $33,388,000 -$23,932,000 -42% 01 Jan 2023 31 Dec 2023 10-K 14 Mar 2025 2024 FY
2022 $57,320,000 -$37,354,000 -39% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $94,674,000 +$413,000 +0.44% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $94,261,000 -$5,534,000 -5.5% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $99,795,000 +$11,694,000 +13% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $88,101,000 +$51,486,000 +141% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $36,615,000 +$10,765,000 +42% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $25,850,000 +$6,181,000 +31% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $19,669,000 +$2,652,000 +16% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $17,017,000 -$691,000 -3.9% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $17,708,000 +$1,509,000 +9.3% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $16,199,000 -$2,686,000 -14% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
2011 $18,885,000 +$1,486,000 +8.5% 01 Jan 2011 31 Dec 2011 10-K 01 Mar 2013 2012 FY
2010 $17,399,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.